Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (r*,s*)-(+-)-8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1h)-quinolinone
2. Ci 888
3. Ci-888
4. Ci888
5. Hydrochloride, Procaterol
6. Monohydrochloride, Procaterol
7. Opc 2009
8. Opc-2009
9. Opc2009
10. Pro Air
11. Pro-air
12. Proair
13. Procaterol
14. Procaterol Monohydrochloride
15. Procaterol Monohydrochloride, (r*,r*)-(+)-isomer
16. Procaterol Monohydrochloride, (r*,r*)-(+-)-isomer
17. Procaterol Monohydrochloride, (r*,r*)-(-)-isomer
18. Procaterol Monohydrochloride, (r*,s*)-(+)-isomer
19. Procaterol Monohydrochloride, (r*,s*)-(-)-isomer
20. Procaterol, (r*,r*)-(+-)-isomer
21. Procaterol, (r*,s*)-(-)-isomer
1. Procaterol Hcl
2. Chebi:32056
3. 62929-91-3
4. 81262-93-3
5. Opc-2009
6. Procaterol Hydrochloride (usan)
7. Ci-888
8. 59828-07-8
9. Pro-air (tn)
10. Mls000028683
11. Schembl124726
12. Chembl1322218
13. Ccg-39328
14. Akos015967634
15. Ac-4219
16. Smr000058864
17. Db-054335
18. Ft-0630735
19. Ft-0630887
20. D02404
21. Q27114767
22. 5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril Hydrochloride
23. 8-hydroxy-5-(1-hydroxy-2-(isopropylamino)butyl)quinolin-2(1h)-one Hydrochloride
Molecular Weight | 326.82 g/mol |
---|---|
Molecular Formula | C16H23ClN2O3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 326.1397203 g/mol |
Monoisotopic Mass | 326.1397203 g/mol |
Topological Polar Surface Area | 81.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 397 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
28
PharmaCompass offers a list of Procaterol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Procaterol manufacturer or Procaterol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Procaterol manufacturer or Procaterol supplier.
PharmaCompass also assists you with knowing the Procaterol API Price utilized in the formulation of products. Procaterol API Price is not always fixed or binding as the Procaterol Price is obtained through a variety of data sources. The Procaterol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PROCATEROL HYDROCHLORIDE HEMIHYDRATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PROCATEROL HYDROCHLORIDE HEMIHYDRATE, including repackagers and relabelers. The FDA regulates PROCATEROL HYDROCHLORIDE HEMIHYDRATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PROCATEROL HYDROCHLORIDE HEMIHYDRATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PROCATEROL HYDROCHLORIDE HEMIHYDRATE supplier is an individual or a company that provides PROCATEROL HYDROCHLORIDE HEMIHYDRATE active pharmaceutical ingredient (API) or PROCATEROL HYDROCHLORIDE HEMIHYDRATE finished formulations upon request. The PROCATEROL HYDROCHLORIDE HEMIHYDRATE suppliers may include PROCATEROL HYDROCHLORIDE HEMIHYDRATE API manufacturers, exporters, distributors and traders.
click here to find a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PROCATEROL HYDROCHLORIDE HEMIHYDRATE DMF (Drug Master File) is a document detailing the whole manufacturing process of PROCATEROL HYDROCHLORIDE HEMIHYDRATE active pharmaceutical ingredient (API) in detail. Different forms of PROCATEROL HYDROCHLORIDE HEMIHYDRATE DMFs exist exist since differing nations have different regulations, such as PROCATEROL HYDROCHLORIDE HEMIHYDRATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PROCATEROL HYDROCHLORIDE HEMIHYDRATE DMF submitted to regulatory agencies in the US is known as a USDMF. PROCATEROL HYDROCHLORIDE HEMIHYDRATE USDMF includes data on PROCATEROL HYDROCHLORIDE HEMIHYDRATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PROCATEROL HYDROCHLORIDE HEMIHYDRATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The PROCATEROL HYDROCHLORIDE HEMIHYDRATE Drug Master File in Japan (PROCATEROL HYDROCHLORIDE HEMIHYDRATE JDMF) empowers PROCATEROL HYDROCHLORIDE HEMIHYDRATE API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the PROCATEROL HYDROCHLORIDE HEMIHYDRATE JDMF during the approval evaluation for pharmaceutical products. At the time of PROCATEROL HYDROCHLORIDE HEMIHYDRATE JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PROCATEROL HYDROCHLORIDE HEMIHYDRATE Drug Master File in Korea (PROCATEROL HYDROCHLORIDE HEMIHYDRATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PROCATEROL HYDROCHLORIDE HEMIHYDRATE. The MFDS reviews the PROCATEROL HYDROCHLORIDE HEMIHYDRATE KDMF as part of the drug registration process and uses the information provided in the PROCATEROL HYDROCHLORIDE HEMIHYDRATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a PROCATEROL HYDROCHLORIDE HEMIHYDRATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PROCATEROL HYDROCHLORIDE HEMIHYDRATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE suppliers with KDMF on PharmaCompass.
PROCATEROL HYDROCHLORIDE HEMIHYDRATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PROCATEROL HYDROCHLORIDE HEMIHYDRATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PROCATEROL HYDROCHLORIDE HEMIHYDRATE GMP manufacturer or PROCATEROL HYDROCHLORIDE HEMIHYDRATE GMP API supplier for your needs.
A PROCATEROL HYDROCHLORIDE HEMIHYDRATE CoA (Certificate of Analysis) is a formal document that attests to PROCATEROL HYDROCHLORIDE HEMIHYDRATE's compliance with PROCATEROL HYDROCHLORIDE HEMIHYDRATE specifications and serves as a tool for batch-level quality control.
PROCATEROL HYDROCHLORIDE HEMIHYDRATE CoA mostly includes findings from lab analyses of a specific batch. For each PROCATEROL HYDROCHLORIDE HEMIHYDRATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PROCATEROL HYDROCHLORIDE HEMIHYDRATE may be tested according to a variety of international standards, such as European Pharmacopoeia (PROCATEROL HYDROCHLORIDE HEMIHYDRATE EP), PROCATEROL HYDROCHLORIDE HEMIHYDRATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PROCATEROL HYDROCHLORIDE HEMIHYDRATE USP).